Powered by

Dr. Carl H. June, Cancer Immunotherapy Pioneer, Joins CytoSorbents Scientific Advisory Board

CytoSorbents Corporation(NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagshipCytoSorb®blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that CAR T-cell cancer immunotherapy pioneer, Dr. Carl H. June, M.D., will join its scientific advisory board to help guide applications of the company's technology in the treatment of cancer.

Dr. Carl June, Director of the Center for Cellular Immunotherapies at

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox